Moreover, our data also demonstrated that teicoplanin was able to potently inhibit the infection of both live SARS-CoV-2 viruses and different pseudotyped SARS-CoV-2 mutants by inhibiting the enzymatic activity of CTSL and preventing S proteins activation in TMPRSS2-deficient cells. This evidence concerns the gene CTSL and infection.